About: covid:PMC7300809

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7300809 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Xu, Wei Kim, John Huang, Shao Bayley, Andrew Bratman, Scott Cho, John Giuliani, Meredith Goldstein, David Hope, Andrew Hosni, Ali Irish, Jonathan Ringash, Jolie Siu, Lillian Spreafico, Anna Waldron, John de Almeida, John Gilbert, Ralph Hansen, Aaron O’Sullivan, Brian Su, Jie Tong, Li
is schema:about of	named entity 'GY PER FRACTION' named entity 'COVID-19 pandemic' named entity 'COVID' named entity 'HPV' named entity 'HPV' named entity 'Data curation' named entity 'p16' named entity 'COVID' named entity 'fractionation' named entity 'data interpretation' named entity 'Bristol-Myers Squibb' named entity 'HPV' named entity 'Oncology' named entity 'statistical significance' named entity 'chemotherapy' named entity 'stage II' named entity 'COVID-19 pandemic' named entity 'HNSCC' named entity 'TNM' named entity 'fractionation' named entity 'Merck' named entity 'fractionation' named entity 'health care sector' named entity 'advanced stage' named entity 'data interpretation' named entity 'hypofractionation' named entity 'chemotherapy' named entity 'chemoradiotherapy' named entity 'chemotherapy' named entity 'HNC' named entity 'data interpretation' named entity 'stage III' named entity 'COVID-19 outbreak' named entity 'Radiation Oncology' named entity '95% CI' named entity 'dose fractionation' named entity 'chemotherapy' named entity 'oropharyngeal' named entity 'Radiation Therapy Oncology Group' named entity 'tumor' named entity 'evidence-based' named entity 'chemotherapy' named entity 'tumors' named entity 'Data curation' named entity 'HPV' named entity 'data interpretation' named entity '95% CI' named entity 'HPV' named entity 'radiotherapy' named entity 'head and neck cancer' named entity 'elderly age' named entity 'Data curation' named entity 'quality assurance' named entity 'effective dose' named entity 'TNM' named entity 'comorbidities' named entity 'chemotherapy' named entity 'multidisciplinary team' named entity 'tumors' named entity 'HPV' named entity 'chemoradiotherapy' named entity 'Data curation' named entity 'chemotherapy' named entity 'sample sizes' named entity 'cetuximab' named entity 'Merck' named entity 'head and neck squamous cell carcinoma' named entity 'Stage IV' named entity 'data curation' named entity 'fractionation' named entity 'Statistical analyses' named entity 'neck surgery' named entity 'chemotherapy' named entity 'cancer care' named entity 'tumors' named entity 'supportive care' named entity 'metastasis' named entity 'HNSCC' named entity 'control arm'

Attributes

Values

Creator

Xu, Wei
Kim, John
Huang, Shao
Bayley, Andrew
Bratman, Scott
Cho, John
Giuliani, Meredith
Goldstein, David
Hope, Andrew
Hosni, Ali
Irish, Jonathan
Ringash, Jolie
Siu, Lillian
Spreafico, Anna
Waldron, John
de Almeida, John
Gilbert, Ralph
Hansen, Aaron
O’Sullivan, Brian
Su, Jie
Tong, Li

is schema:about of

named entity 'GY PER FRACTION'
named entity 'COVID-19 pandemic'
named entity 'COVID'
named entity 'HPV'
named entity 'HPV'
named entity 'Data curation'
named entity 'p16'
named entity 'COVID'
named entity 'fractionation'
named entity 'data interpretation'
named entity 'Bristol-Myers Squibb'
named entity 'HPV'
named entity 'Oncology'
named entity 'statistical significance'
named entity 'chemotherapy'
named entity 'stage II'
named entity 'COVID-19 pandemic'
named entity 'HNSCC'
named entity 'TNM'
named entity 'fractionation'
named entity 'Merck'
named entity 'fractionation'
named entity 'health care sector'
named entity 'advanced stage'
named entity 'data interpretation'
named entity 'hypofractionation'
named entity 'chemotherapy'
named entity 'chemoradiotherapy'
named entity 'chemotherapy'
named entity 'HNC'
named entity 'data interpretation'
named entity 'stage III'
named entity 'COVID-19 outbreak'
named entity 'Radiation Oncology'
named entity '95% CI'
named entity 'dose fractionation'
named entity 'chemotherapy'
named entity 'oropharyngeal'
named entity 'Radiation Therapy Oncology Group'
named entity 'tumor'
named entity 'evidence-based'
named entity 'chemotherapy'
named entity 'tumors'
named entity 'Data curation'
named entity 'HPV'
named entity 'data interpretation'
named entity '95% CI'
named entity 'HPV'
named entity 'radiotherapy'
named entity 'head and neck cancer'
named entity 'elderly age'
named entity 'Data curation'
named entity 'quality assurance'
named entity 'effective dose'
named entity 'TNM'
named entity 'comorbidities'
named entity 'chemotherapy'
named entity 'multidisciplinary team'
named entity 'tumors'
named entity 'HPV'
named entity 'chemoradiotherapy'
named entity 'Data curation'
named entity 'chemotherapy'
named entity 'sample sizes'
named entity 'cetuximab'
named entity 'Merck'
named entity 'head and neck squamous cell carcinoma'
named entity 'Stage IV'
named entity 'data curation'
named entity 'fractionation'
named entity 'Statistical analyses'
named entity 'neck surgery'
named entity 'chemotherapy'
named entity 'cancer care'
named entity 'tumors'
named entity 'supportive care'
named entity 'metastasis'
named entity 'HNSCC'
named entity 'control arm'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software